quinoxalines has been researched along with Kidney, Polycystic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Namkung, W; Sonawane, ND; Tradtrantip, L; Verkman, AS | 1 |
| Anderson, MO; Synder, D; Thiagarajah, JR; Tradtrantip, L; Verkman, AS | 1 |
1 review(s) available for quinoxalines and Kidney, Polycystic
| Article | Year |
|---|---|
CFTR inhibitors.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Discovery; Glycine; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Mutation; Polycystic Kidney Diseases; Quinoxalines; Small Molecule Libraries; Thiazolidinediones | 2013 |
1 other study(ies) available for quinoxalines and Kidney, Polycystic
| Article | Year |
|---|---|
Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model.
Topics: Animals; Cell Line; Cystic Fibrosis Transmembrane Conductance Regulator; Cysts; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Inhibitory Concentration 50; Membrane Potentials; Mice; Polycystic Kidney Diseases; Quinoxalines; Rats; Structure-Activity Relationship | 2009 |